Author:
Fazzi P.,Manni E.,Cristofani R.,Cei G.,Piazza S.,Calabrese R.,Antonelli A.,Siciliano G.,Barachini P.,Carpi A.
Subject
Pharmacology,General Medicine
Reference46 articles.
1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736–55.
2. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes;Crystal;Ann Intern Med,1981
3. Corticosteroid treatment in sarcoidosis;Grutters;Eur Respir J,2006
4. Treatments for pulmonary sarcoidosis;Paramothayan;Respir Med,2008
5. Treatment of progressive pulmonary sarcoidosis with cyclosporin A. A randomized controlled trial;Wyser;Am J Respir Crit Care Med,1997
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Thalidomide for management of refractory oral mucosal diseases;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-04
2. Sarcoidosis;Rook's Textbook of Dermatology;2024-03-19
3. Cutaneous Sarcoidosis;Clinics in Chest Medicine;2024-03
4. Re-evaluating serum angiotensin-converting enzyme in sarcoidosis;Frontiers in Immunology;2023-10-05
5. Sarcoidosis;European Handbook of Dermatological Treatments;2023